Healthcare provider profile · identity verified

Sushama Jampani, M.D.

Internal Medicine · NASHUA, NH · NPI 1710063441

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	642	194
Levothyroxine Sodium	Levothyroxine Sodium	449	125
Amlodipine Besylate	Amlodipine Besylate	437	130
Lisinopril	Lisinopril	332	99
Hydrochlorothiazide	Hydrochlorothiazide	311	93
Rosuvastatin Calcium	Rosuvastatin Calcium	251	77
Omeprazole	Omeprazole	247	81
Losartan Potassium	Losartan Potassium	230	69
Pantoprazole Sodium	Pantoprazole Sodium	207	60
Simvastatin	Simvastatin	199	54
Gabapentin	Gabapentin	166	44
Metoprolol Succinate	Metoprolol Succinate	163	47
Atenolol	Atenolol	139	41
Lorazepam	Lorazepam	126	47
Pravastatin Sodium	Pravastatin Sodium	109	27
Valsartan	Valsartan	106	38
Metformin Hcl	Metformin Hcl	102	31
Trazodone Hcl	Trazodone Hcl	102	28
Sertraline Hcl	Sertraline Hcl	100	24
Eliquis	Apixaban	98	25
Zolpidem Tartrate	Zolpidem Tartrate	97	26
Furosemide	Furosemide	92	29
Metoprolol Tartrate	Metoprolol Tartrate	90	27
Celecoxib	Celecoxib	86	17
Tramadol Hcl	Tramadol Hcl	83	27
Escitalopram Oxalate	Escitalopram Oxalate	81	26
Allopurinol	Allopurinol	80	18
Alprazolam	Alprazolam	76	25
Montelukast Sodium	Montelukast Sodium	70	20
Olmesartan Medoxomil	Olmesartan Medoxomil	66	18
Albuterol Sulfate Hfa	Albuterol Sulfate	60	37
Tamsulosin Hcl	Tamsulosin Hcl	59	17
Clonazepam	Clonazepam	57	12
Duloxetine Hcl	Duloxetine Hcl	57	16
Bupropion Xl	Bupropion Hcl	56	12
Citalopram Hbr	Citalopram Hydrobromide	53	18
Famotidine	Famotidine	53	23
Venlafaxine Hcl Er	Venlafaxine Hcl	53	14
Clopidogrel	Clopidogrel Bisulfate	52	16
Meloxicam	Meloxicam	52	24
Metformin Hcl Er	Metformin Hcl	50	15
Fluoxetine Hcl	Fluoxetine Hcl	49	15
Meclizine Hcl	Meclizine Hcl	48	17
Fluticasone Propionate	Fluticasone Propionate	46	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	15
Potassium Chloride	Potassium Chloride	46	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	13
Synthroid	Levothyroxine Sodium	41	13
Enalapril Maleate	Enalapril Maleate	38	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	11
Xarelto	Rivaroxaban	38	suppressed
Spironolactone	Spironolactone	35	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Prednisone	Prednisone	30	27
Carvedilol	Carvedilol	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	25
Doxycycline Hyclate	Doxycycline Hyclate	29	27
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	19
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	21
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Cephalexin	Cephalexin	23	22
Irbesartan	Irbesartan	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Finasteride	Finasteride	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Torsemide	Torsemide	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Nystatin	Nystatin	18	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Amoxicillin	Amoxicillin	16	15
Diazepam	Diazepam	16	suppressed
Digoxin	Digoxin	16	suppressed
Estradiol	Estradiol	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Azathioprine	Azathioprine	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Ozempic	Semaglutide	15	suppressed
Tiadylt Er	Diltiazem Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Azithromycin	Azithromycin	14	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	12
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Mirabegron Er	Mirabegron	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Restasis	Cyclosporine	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Baclofen	Baclofen	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error